Stifel Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $175
KeyBanc Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $216
Mizuho Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $215
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $215
Inspire Medical Systems Is Maintained at Outperform by RBC Capital
Inspire Medical Systems Analyst Ratings
RBC Cuts Price Target on Inspire Medical Systems to $215 From $260, Keeps Outperform Rating
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $210
Piper Sandler Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $233
Inspire Medical Systems (INSP) Receives a Buy From Piper Sandler
UBS Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $265
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $260
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $194 to $270
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Vertex Pharmaceuticals (VRTX) and Incyte (INCY)
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $190 to $260
Inspire Medical Systems Is Maintained at Overweight by Morgan Stanley
Inspire Medical Systems Price Target Cut to $220.00/Share From $230.00 by Morgan Stanley
Wells Fargo Maintains Equal-Weight on Inspire Medical Systems, Lowers Price Target to $195
J.P. Morgan Reaffirms Their Buy Rating on Inspire Medical Systems (INSP)
Stifel Nicolaus Sticks to Its Hold Rating for Inspire Medical Systems (INSP)